Free tool · about 4 minutes
Thinking of stopping? Make a plan first.
Most people who stop a GLP-1 medicine regain part of the weight. That isn’t failure. It’s a reason to plan, with your prescriber, before you stop.
Reviewed by the Kenning clinical and outcomes research team · Updated November 2026
This tool doesn’t tell you whether to stop. Your answers stay on this device.
2 in 3
people without diabetes stopped their GLP-1 medicine within a year, in a study of 125,474 US adults.
Rodriguez et al., JAMA Network Open, 2025
Your stopping plan
Before, during and after
ready
Before you stop
First 3 months after
3 to 12 months after
My call-my-clinician line
Agree this with your clinician before you stop, so the decision is already made if it happens.
If my weight goes up by more than
If my waist goes past cm
If my blood sugar goes past
Then I will
Questions for your prescriber
This plan is education, not medical advice. Don’t stop, restart or change the dose of any medicine without talking to your prescriber.
Check in at three months
We’ll send one reminder to redo your Mirror Four, and nothing else unless you ask.
+ Where this comes from
- Rodriguez PJ, et al. Discontinuation and reinitiation of GLP-1 receptor agonists. JAMA Network Open, 2025.
- Wilding JPH, et al. Weight regain after withdrawal of semaglutide: STEP 1 extension. Diabetes, Obesity and Metabolism, 2022.
- Aronne LJ, et al. SURMOUNT-4. JAMA, 2024.
- Wegovy (semaglutide) prescribing information: pregnancy and stopping.
- Watson SL, et al. LIFTMOR. Journal of Bone and Mineral Research, 2018.
- Bauer J, et al. PROT-AGE protein recommendations. JAMDA, 2013.
- Nguyen N, Lu J. The Mirror and the Medicine, Chapters 7, 14 and 16. Kenning Health, 2027.
There is little trial evidence on whether stepping down the dose works better than stopping at once. Ask your prescriber. Kenning provides education, not medical advice, diagnosis or treatment.